These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7837143)

  • 1. Mucocutaneous reactions to gold: a prospective study of 74 patients with rheumatoid arthritis.
    van Gestel A; Koopman R; Wijnands M; van de Putte L; van Riel P
    J Rheumatol; 1994 Oct; 21(10):1814-9. PubMed ID: 7837143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HLA-B35 with mucocutaneous lesions in Israeli patients with rheumatoid arthritis receiving gold treatment.
    Tishler M; Caspi D; Gazit E; Yaron M
    Ann Rheum Dis; 1988 Mar; 47(3):215-7. PubMed ID: 2965554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-DR5 with mucocutaneous lesions in patients with rheumatoid arthritis receiving gold sodium thiomalate.
    Rodriguez-Pérez M; González-Dominguez J; Matarán L; Garcia-Pérez S; Salvatierra D
    J Rheumatol; 1994 Jan; 21(1):41-3. PubMed ID: 8151585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous side effects of gold therapy. Clinical and histologic results].
    Hofmann C; Burg G; Jung C
    Z Rheumatol; 1986; 45(3):100-6. PubMed ID: 2944308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable gold dermatitis and proteinuria: retreatment with auranofin.
    Tosi S; Cagnoli M; Guidi G; Murelli M; Messina K; Colombo B
    Int J Clin Pharmacol Res; 1985; 5(4):265-8. PubMed ID: 2932399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens and toxic reactions to sodium aurothiomalate in patients with rheumatoid arthritis.
    Bensen WG; Moore N; Tugwell P; D'Souza M; Singal DP
    J Rheumatol; 1984 Jun; 11(3):358-61. PubMed ID: 6234391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral gold preparations. Efficacy and safety of therapy after switching from aurothioglucose to aurothiomalate.
    van Roon EN; van de Laar MA; Janssen M; Kruijsen MW; Jansen TL; Brouwers JR
    J Rheumatol; 2005 Jun; 32(6):1026-30. PubMed ID: 15940762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gold treatment of progressive chronic polyarthritis--a clinical study].
    Knoche U; Wagner H; Hauss WH
    Z Rheumatol; 1975; 34(5-6):203-12. PubMed ID: 779340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinstitution of gold therapy in rheumatoid arthritis after mucocutaneous reactions.
    Klinefelter
    J Rheumatol; 1975 Mar; 2(1):21-7. PubMed ID: 127042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lichenoid eruptions after gold therapy. Report of two cases].
    Lasarowa AZ; Tsankov NK; Stoimenov AP
    Hautarzt; 1992 Aug; 43(8):514-6. PubMed ID: 1387122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitritoid reactions: case reports, review, and recommendations for management.
    Arthur AB; Klinkhoff A; Teufel A
    J Rheumatol; 2001 Oct; 28(10):2209-12. PubMed ID: 11669157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis.
    Davis P; Menard H; Thompson J; Harth M; Beaudet F
    J Rheumatol; 1985 Feb; 12(1):60-7. PubMed ID: 3920393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IV N-acetylcysteine treatment of hematologic reactions to chrysotherapy.
    Godfrey NF; Peter A; Simon TM; Lorber A
    J Rheumatol; 1982; 9(4):519-26. PubMed ID: 6813467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gold dermatitis. A clinical and histopathological study.
    Penneys NS; Ackerman AB; Gottlieb NL
    Arch Dermatol; 1974 Mar; 109(3):372-6. PubMed ID: 4273615
    [No Abstract]   [Full Text] [Related]  

  • 18. How low can you go? Use of very low dosage of gold in patients with mucocutaneous reactions.
    Klinkhoff AV; Teufel A
    J Rheumatol; 1995 Sep; 22(9):1657-9. PubMed ID: 8523340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sulfasalazine (Azulfidine RA) versus aurothioglucose in therapy of chronic polyarthritis--status report of an open, comparative, multicenter long-term study].
    Schattenkirchner M
    Z Rheumatol; 1987; 46(2):67-70. PubMed ID: 2885986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of eosinophilia during gold therapy for rheumatoid arthritis.
    Edelman J; Davis P; Owen ET
    J Rheumatol; 1983 Feb; 10(1):121-3. PubMed ID: 6405032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.